Abogen Patents

Patent portfolio assigned to Abogen (verified via public assignee records). Chinese mRNA vaccine/therapeutics developer (Suzhou Abogen Biosciences). Pre-commercial drug developer, no named notable customers. Has patents: Jones Day confirms Abogen 'established global patent portfolios for mRNA-based vaccines and nano-delivery platform technologies'; Justia lists Suzhou Abogen Biosciences as assignee. Exact count not visible, estimate 0.